Peters Thomas Phineas 13D/13G Filings for Nuvectis Pharma, Inc. (NVCT)

Peters Thomas Phineas 13D and 13G filings for Nuvectis Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-01-30
9:01 pm
Sale		 2023-12-31 13G Nuvectis Pharma, Inc.
NVCT		 Peters Thomas Phineas 908,475
5.200%		 -39,183decrease
(-4.13%)		 Filing
2023-04-03
08:15 am
Purchase		 2022-02-04 13G Nuvectis Pharma, Inc.
NVCT		 Peters Thomas Phineas 947,658
6.400%		 947,658increase
(New Position)		 Filing